GI Biopharma Inc
GI Biopharma Inc, located in East Hanover, NJ, is dedicated to developing innovative treatments for inflammatory bowel disease (IBD) and other health issues related to gut microbiota dysbiosis. The company focuses on addressing the underlying causes of these conditions, emphasizing the role of digestive proteases and gut bacteria in maintaining gut health.
Grounded in extensive research, GI Biopharma's approach aims to combat the growing prevalence of gut-related diseases by exploring the mechanisms behind impaired digestive enzyme function caused by gut dysbiosis. Their work highlights the critical connection between gut health and a range of modern societal health challenges.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.

